MedTrace Logo

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

NCT04939987 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2022-09-06

No results posted yet for this study

Summary

This study will address the gaps in research of non-opioid postoperative pain management for prostatectomies.

Conditions

  • Radical Prostatectomies

Interventions

DRUG

Tramadol

Opioid Control Cohort (One treatment selected)

DRUG

Gabapentin

Experimental Cohort (Multimodal Approach)

DRUG

Hydrocodone-Acetaminophen

Opioid Control Cohort (One treatment selected)

DRUG

Oxycodone-Acetaminophen

Opioid Control Cohort (One treatment selected)

DRUG

Ketorolac

Experimental Cohort (Multimodal Approach)

DRUG

Acetaminophen

Experimental Cohort (Multimodal Approach)

DRUG

Ketorolac tromethamine

Experimental Cohort (Multimodal Approach)

DRUG

Ketamine

Experimental Cohort (Multimodal Approach)

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Ram Pathak, MD · Wake Forest Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-31
Primary Completion
2022-10-31
Completion
2022-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04939987 on ClinicalTrials.gov